Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth

被引:116
作者
Takeda, K
Smyth, MJ
Cretney, E
Hayakawa, Y
Yamaguchi, N
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Peter MacCallum Canc Inst, Sir Donald & Lady Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia
[3] Toyama Med & Pharmaceut Univ, Res Inst Nat Med, Dept Pathogan Biochem, Toyama 9300194, Japan
[4] Juntendo Univ, Sch Med, Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan
基金
英国医学研究理事会;
关键词
TRAIL; NK cells; IFN-gamma; tumor growth;
D O I
10.1006/cimm.2001.1896
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NK) cells and interferon- (IFN) gamma have been implicated in immune surveillance against tumor development. Here we show tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which is a type II membrane protein belonging to the TNF family and plays a critical role in the NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous growth of TRAIL-sensitive tumors. Administration of a neutralizing monoclonal antibody against TRAIL promoted outgrowth of subcutaneously inoculated TRAIL-sensitive tumors (L929, LB27.4, and Renca) but not TRAIL-resistant tumors (P815 and 1316). Such a protective effect of TRAIL against TRAIL-sensitive tumors was abrogated in NK cell-depleted or IFN-gamma-deficient mice. These results suggested a substantial role of TRAIL as the effector molecule that eliminates subcutaneously developing TRAIL-sensitive tumors. (C) 2001 Elsevier Science (USA).
引用
收藏
页码:194 / 200
页数:7
相关论文
共 31 条
  • [1] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [2] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [3] BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005
  • [4] Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Fanger, NA
    Maliszewski, CR
    Schooley, K
    Griffith, TS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) : 1155 - 1164
  • [5] Cell death: TRAIL and its receptors
    Golstein, P
    [J]. CURRENT BIOLOGY, 1997, 7 (12) : R750 - R753
  • [6] Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
    Griffith, TS
    Wiley, SR
    Kubin, MZ
    Sedger, LM
    Maliszewski, CR
    Fanger, NA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) : 1343 - 1353
  • [7] Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO
  • [8] 2-U
  • [9] Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
    Kaplan, DH
    Shankaran, V
    Dighe, AS
    Stockert, E
    Aguet, M
    Old, LJ
    Schreiber, RD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) : 7556 - 7561
  • [10] Kayagaki N, 1999, J IMMUNOL, V163, P1906